{"count": 26, "results": [{"_id": "37737447", "pmid": 37737447, "pmcid": "PMC10747420", "title": "New insights on the potential anti-epileptic effect of metformin: Mechanistic pathway", "journal": "J Cell Mol Med", "authors": ["Alnaaim SA", "Al-Kuraishy HM", "Al-Gareeb AI", "Ali NH", "Alexiou A", "Papadakis M", "Saad HM", "Batiha GE"], "date": "2023-09-22T00:00:00Z", "doi": "10.1111/jcmm.17965", "meta_date_publication": "2023 Sep 22", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50284.41, "text_hl": "New insights on the potential anti-@<m>DISEASE_Epilepsy</m> @DISEASE_MESH:D004827 @@@epileptic@@@ effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@: Mechanistic pathway", "citations": {"NLM": "Alnaaim SA, Al-Kuraishy HM, Al-Gareeb AI, Ali NH, Alexiou A, Papadakis M, Saad HM, Batiha GE. New insights on the potential anti-epileptic effect of metformin: Mechanistic pathway J Cell Mol Med. 2023 Sep 22;():. PMID: 37737447", "BibTeX": "@article{37737447, title={New insights on the potential anti-epileptic effect of metformin: Mechanistic pathway}, author={Alnaaim SA and Al-Kuraishy HM and Al-Gareeb AI and Ali NH and Alexiou A and Papadakis M and Saad HM and Batiha GE}, journal={J Cell Mol Med}}"}}, {"_id": "34069559", "pmid": 34069559, "pmcid": "PMC8160983", "title": "Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease", "journal": "Int J Mol Sci", "authors": ["Sanz P", "Serratosa JM", "Sánchez MP"], "date": "2021-05-19T00:00:00Z", "doi": "10.3390/ijms22105351", "meta_date_publication": "2021 May 19", "meta_volume": "22", "meta_issue": "10", "meta_pages": "", "score": 50267.1, "text_hl": "Beneficial Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ on the Central @DISEASE_Nervous_System_Diseases @DISEASE_MESH:D009422 @@@Nervous@@@ System, with a Focus on @<m>DISEASE_Epilepsy</m> @DISEASE_MESH:D004827 @@@Epilepsy@@@ and @DISEASE_Lafora_Disease @DISEASE_MESH:D020192 @@@Lafora Disease@@@", "citations": {"NLM": "Sanz P, Serratosa JM, Sánchez MP. Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease Int J Mol Sci. 2021 May 19;22(10):. PMID: 34069559", "BibTeX": "@article{34069559, title={Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease}, author={Sanz P and Serratosa JM and Sánchez MP}, journal={Int J Mol Sci}, volume={22}, number={10}}"}}, {"_id": "37175220", "pmid": 37175220, "pmcid": "PMC10179922", "title": "Anticonvulsant Profile of Selected Medium-Chain Fatty Acids (MCFAs) Co-Administered with Metformin in Mice in Acute and Chronic Treatment", "journal": "Molecules", "authors": ["Pieróg M", "Socała K", "Nieoczym D", "Wyska E", "Samorek-Pieróg M", "Wlaź P"], "date": "2023-04-29T00:00:00Z", "doi": "10.3390/molecules28093810", "meta_date_publication": "2023 Apr 29", "meta_volume": "28", "meta_issue": "9", "meta_pages": "", "score": 50265.125, "text_hl": "More research is needed to explain its action in @<m>DISEASE_Epilepsy</m> @DISEASE_MESH:D004827 @@@epilepsy@@@. The clinical pharmacokinetics of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ are well characterized in @SPECIES_9606 @@@humans@@@. ", "citations": {"NLM": "Pieróg M, Socała K, Nieoczym D, Wyska E, Samorek-Pieróg M, Wlaź P. Anticonvulsant Profile of Selected Medium-Chain Fatty Acids (MCFAs) Co-Administered with Metformin in Mice in Acute and Chronic Treatment Molecules. 2023 Apr 29;28(9):. PMID: 37175220", "BibTeX": "@article{37175220, title={Anticonvulsant Profile of Selected Medium-Chain Fatty Acids (MCFAs) Co-Administered with Metformin in Mice in Acute and Chronic Treatment}, author={Pieróg M and Socała K and Nieoczym D and Wyska E and Samorek-Pieróg M and Wlaź P}, journal={Molecules}, volume={28}, number={9}}"}}, {"_id": "36116284", "pmid": 36116284, "title": "A review on role of metformin as a potential drug for epilepsy treatment and modulation of epileptogenesis.", "journal": "Seizure", "authors": ["Singh R", "Sarangi SC", "Singh S", "Tripathi M"], "date": "2022-10-01T00:00:00Z", "doi": "10.1016/j.seizure.2022.09.003", "meta_date_publication": "2022 Oct", "meta_volume": "101", "meta_issue": "", "meta_pages": "253-261", "score": 50263.387, "text_hl": "A review on role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as a potential drug for @<m>DISEASE_Epilepsy</m> @DISEASE_MESH:D004827 @@@epilepsy@@@ treatment and modulation of epileptogenesis.", "citations": {"NLM": "Singh R, Sarangi SC, Singh S, Tripathi M. A review on role of metformin as a potential drug for epilepsy treatment and modulation of epileptogenesis. Seizure. 2022 Oct;101():253-261. PMID: 36116284", "BibTeX": "@article{36116284, title={A review on role of metformin as a potential drug for epilepsy treatment and modulation of epileptogenesis.}, author={Singh R and Sarangi SC and Singh S and Tripathi M}, journal={Seizure}, volume={101}, pages={253-261}}"}}, {"_id": "36833359", "pmid": 36833359, "pmcid": "PMC9957184", "title": "Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways:Case Report and Literature Review", "journal": "Genes (Basel)", "authors": ["Jurca CM", "Kozma K", "Petchesi CD", "Zaha DC", "Magyar I", "Munteanu M", "Faur L", "Jurca A", "Bembea D", "Severin E", "Jurca AD"], "date": "2023-02-08T00:00:00Z", "doi": "10.3390/genes14020433", "meta_date_publication": "2023 Feb 8", "meta_volume": "14", "meta_issue": "2", "meta_pages": "", "score": 50255.926, "text_hl": "The study followed the evolution of @DISEASE_Angiomyolipoma @DISEASE_MESH:D018207 @@@angiomyolipomas@@@, @DISEASE_Glioma_Subependymal @DISEASE_MESH:D018315 @@@subependymal astrocytomas@@@ and @<m>DISEASE_Epilepsy</m> @DISEASE_MESH:D004827 @@@epileptic seizures@@@ in @SPECIES_9606 @@@patients@@@ who were treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ as compared to those treated with placebo medication. ", "citations": {"NLM": "Jurca CM, Kozma K, Petchesi CD, Zaha DC, Magyar I, Munteanu M, Faur L, Jurca A, Bembea D, Severin E, Jurca AD. Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways:Case Report and Literature Review Genes (Basel). 2023 Feb 8;14(2):. PMID: 36833359", "BibTeX": "@article{36833359, title={Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways:Case Report and Literature Review}, author={Jurca CM and Kozma K and Petchesi CD and Zaha DC and Magyar I and Munteanu M and Faur L and Jurca A and Bembea D and Severin E and Jurca AD}, journal={Genes (Basel)}, volume={14}, number={2}}"}}, {"_id": "40928653", "pmid": 40928653, "title": "Adjuvant potential of metformin with standard anti-seizure medications in persons with active epilepsy: a randomised controlled trial.", "journal": "Naunyn Schmiedebergs Arch Pharmacol", "authors": ["Sarangi SC", "Pattnaik SS", "Singh R", "Dash Y", "Tripathi M", "Singh S", "Khan MA"], "date": "2025-09-10T00:00:00Z", "doi": "10.1007/s00210-025-04561-6", "meta_date_publication": "2025 Sep 10", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50252.71, "text_hl": "Adjuvant potential of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ with standard anti-@DISEASE_Seizures @DISEASE_MESH:D012640 @@@seizure medications@@@ in @SPECIES_9606 @@@persons@@@ with active @<m>DISEASE_Epilepsy</m> @DISEASE_MESH:D004827 @@@epilepsy@@@: a randomised controlled trial.", "citations": {"NLM": "Sarangi SC, Pattnaik SS, Singh R, Dash Y, Tripathi M, Singh S, Khan MA. Adjuvant potential of metformin with standard anti-seizure medications in persons with active epilepsy: a randomised controlled trial. Naunyn Schmiedebergs Arch Pharmacol. 2025 Sep 10;():. PMID: 40928653", "BibTeX": "@article{40928653, title={Adjuvant potential of metformin with standard anti-seizure medications in persons with active epilepsy: a randomised controlled trial.}, author={Sarangi SC and Pattnaik SS and Singh R and Dash Y and Tripathi M and Singh S and Khan MA}, journal={Naunyn Schmiedebergs Arch Pharmacol}}"}}, {"_id": "32679167", "pmid": 32679167, "title": "The possible role of progranulin on anti-inflammatory effects of metformin in temporal lobe epilepsy.", "journal": "J Chem Neuroanat", "authors": ["Vazifehkhah S", "Khanizadeh AM", "Mojarad TB", "Nikbakht F"], "date": "2020-11-01T00:00:00Z", "doi": "10.1016/j.jchemneu.2020.101849", "meta_date_publication": "2020 Nov", "meta_volume": "109", "meta_issue": "", "meta_pages": "101849", "score": 50251.81, "text_hl": "@DISEASE_Epilepsy_Temporal_Lobe @DISEASE_MESH:D004833 @@@TLE@@@ was induced by intracerebroventricular microinjection of @CHEMICAL_Kainic_Acid @CHEMICAL_MESH:D007608 @@@kainic acid@@@. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ was orally administered for two weeks before the induction of @<m>DISEASE_Epilepsy</m> @DISEASE_MESH:D004827 @@@epilepsy@@@. ", "citations": {"NLM": "Vazifehkhah S, Khanizadeh AM, Mojarad TB, Nikbakht F. The possible role of progranulin on anti-inflammatory effects of metformin in temporal lobe epilepsy. J Chem Neuroanat. 2020 Nov;109():101849. PMID: 32679167", "BibTeX": "@article{32679167, title={The possible role of progranulin on anti-inflammatory effects of metformin in temporal lobe epilepsy.}, author={Vazifehkhah S and Khanizadeh AM and Mojarad TB and Nikbakht F}, journal={J Chem Neuroanat}, volume={109}, pages={101849}}"}}, {"_id": "38010498", "pmid": 38010498, "title": "AMPK role in epilepsy: a promising therapeutic target?", "journal": "J Neurol", "authors": ["Qi Y", "Zhang YM", "Gao YN", "Chen WG", "Zhou T", "Chang L", "Zang Y", "Li J"], "date": "2023-11-27T00:00:00Z", "doi": "10.1007/s00415-023-12062-w", "meta_date_publication": "2023 Nov 27", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50251.258, "text_hl": "Despite the potential of @GENE_PRKAA1 @GENE_5562 @@@AMPK@@@-targeted therapies, several aspects warrant further exploration, including the detailed mechanisms of @GENE_PRKAA1 @GENE_5562 @@@AMPK@@@'s role in different brain regions, the impact of @GENE_PRKAA1 @GENE_5562 @@@AMPK@@@ under various conditional circumstances such as @DISEASE_Wounds_and_Injuries @DISEASE_MESH:D014947 @@@neural injury@@@ and zinc toxicity, the long-term safety and efficacy of chronic @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use in @<m>DISEASE_Epilepsy</m> @DISEASE_MESH:D004827 @@@epilepsy@@@ treatment, and the potential benefits of combination therapy involving @GENE_PRKAA1 @GENE_5562 @@@AMPK@@@ activators. ", "citations": {"NLM": "Qi Y, Zhang YM, Gao YN, Chen WG, Zhou T, Chang L, Zang Y, Li J. AMPK role in epilepsy: a promising therapeutic target? J Neurol. 2023 Nov 27;():. PMID: 38010498", "BibTeX": "@article{38010498, title={AMPK role in epilepsy: a promising therapeutic target?}, author={Qi Y and Zhang YM and Gao YN and Chen WG and Zhou T and Chang L and Zang Y and Li J}, journal={J Neurol}}"}}, {"_id": "32652135", "pmid": 32652135, "title": "Evaluation of the ameliorative effects of oral administration of metformin on epileptogenesis in the temporal lobe epilepsy model in rats.", "journal": "Life Sci", "authors": ["Vazifehkhah S", "Ali MK", "Babae JF", "Hashemi P", "Alireza MS", "Nikbakht F"], "date": "2020-09-15T00:00:00Z", "doi": "10.1016/j.lfs.2020.118066", "meta_date_publication": "2020 Sep 15", "meta_volume": "257", "meta_issue": "", "meta_pages": "118066", "score": 50251.07, "text_hl": "This study was designed to evaluate the ameliorative effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on the progression of @<m>DISEASE_Epilepsy</m> @DISEASE_MESH:D004827 @@@epilepsy@@@ in the @DISEASE_Epilepsy_Temporal_Lobe @DISEASE_MESH:D004833 @@@temporal lobe epilepsy@@@ model in @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Vazifehkhah S, Ali MK, Babae JF, Hashemi P, Alireza MS, Nikbakht F. Evaluation of the ameliorative effects of oral administration of metformin on epileptogenesis in the temporal lobe epilepsy model in rats. Life Sci. 2020 Sep 15;257():118066. PMID: 32652135", "BibTeX": "@article{32652135, title={Evaluation of the ameliorative effects of oral administration of metformin on epileptogenesis in the temporal lobe epilepsy model in rats.}, author={Vazifehkhah S and Ali MK and Babae JF and Hashemi P and Alireza MS and Nikbakht F}, journal={Life Sci}, volume={257}, pages={118066}}"}}, {"_id": "40042558", "pmid": 40042558, "title": "Effect of solid lipid nanoparticles loaded with valproate and metformin on pentylenetetrazole-induced epilepsy in rats.", "journal": "Naunyn Schmiedebergs Arch Pharmacol", "authors": ["Abinaya R", "Kalaichelvan VK", "Gopalasatheeskumar K"], "date": "2025-03-05T00:00:00Z", "doi": "10.1007/s00210-025-03983-6", "meta_date_publication": "2025 Mar 5", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50250.074, "text_hl": "Effect of solid @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ nanoparticles loaded with @CHEMICAL_Valproic_Acid @CHEMICAL_MESH:D014635 @@@valproate@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @CHEMICAL_Pentylenetetrazole @CHEMICAL_MESH:D010433 @@@pentylenetetrazole@@@-induced @<m>DISEASE_Epilepsy</m> @DISEASE_MESH:D004827 @@@epilepsy@@@ in @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Abinaya R, Kalaichelvan VK, Gopalasatheeskumar K. Effect of solid lipid nanoparticles loaded with valproate and metformin on pentylenetetrazole-induced epilepsy in rats. Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 5;():. PMID: 40042558", "BibTeX": "@article{40042558, title={Effect of solid lipid nanoparticles loaded with valproate and metformin on pentylenetetrazole-induced epilepsy in rats.}, author={Abinaya R and Kalaichelvan VK and Gopalasatheeskumar K}, journal={Naunyn Schmiedebergs Arch Pharmacol}}"}}]}